Insulin Glargine-Aglr
1 NDC across 1 manufacturer|0 Generic,1 Brand
Insulin Glargine-Aglr is used to treat type 1 diabetes mellitus, type 2 diabetes mellitus and hyperglycemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $586K on Insulin Glargine-Aglr across 6,554 claims for 2,344 beneficiaries.
Insulin Glargine-Aglr is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $5.92 to $5.92 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$5.92 – $5.92
per ML
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Eli Lilly and Company manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Insulin Analog class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing INSULIN GLARGINE-AGLR
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
REZVOGLAR 100 UNIT/ML KWIKPEN | $5.9216 per ML | +0.03% |
Frequently Asked Questions
What is Insulin Glargine-Aglr used to treat?
Insulin Glargine-Aglr is used to treat type 1 diabetes mellitus, type 2 diabetes mellitus and hyperglycemia, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Insulin Glargine-Aglr?
In 2024, Medicare Part D spent $586K on Insulin Glargine-Aglr across 6,554 claims for 2,344 beneficiaries.
How many Insulin Glargine-Aglr products are on the market?
The Insulin Glargine-Aglr drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Insulin Glargine-Aglr?
NADAC reference prices for Insulin Glargine-Aglr range from $5.9216 to $5.9216 per ML.
Which manufacturers make Insulin Glargine-Aglr?
1 manufacturer lists Insulin Glargine-Aglr in NADAC. Ranked by number of NDCs, the largest are Eli Lilly and Company (1).
How has the price of Insulin Glargine-Aglr changed recently?
Over the past 7 days, 1 Insulin Glargine-Aglr NDC rose and 0 fell, with a market-wide average change of +0.0%.